Blog

ASCO 2018: Immunotherapy-Based Approaches for Advanced Urothelial Cancer – UroToday

ASCO 2018: Immunotherapy-Based Approaches for Advanced Urothelial Cancer
UroToday
There are no reliable, predictive biomarkers; There is a relatively low number of responders and we are unclear as to the duration of therapy for those that do respond; We are still unsure what the best setting to use immunotherapy is; Will sequence

and more »

2018-06-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.